Lustberg, Maryam
Fan-Havard, Patty
Wong, F. Lennie
Hill, Kasey
Phelps, Mitch A.
Herrera, Kevin W.
Tsai, Ni-Chun
Synold, Timothy
Feng, Ye
Kalu, Chidimma
Sedrak, Mina S.
Yee, Lisa D. http://orcid.org/0000-0001-8243-1055
Clinical trials referenced in this document:
Documents that mention this clinical trial
Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial
https://doi.org/10.1007/s10549-023-07223-4
Funding for this research was provided by:
National Cancer Institute (UG1 CA189823, UG1 CA189823, UG1 CA233331, UG1 CA233337)
Comprehensive Cancer Center, City of Hope (P30CA033572)
Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (P30CA016058)
City of Hope
Article History
Received: 7 October 2023
Accepted: 10 December 2023
First Online: 27 January 2024
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: All patients provided written informed consent before participating in the study.